Health & Fitness
Health and Fitness
Health and Fitness
Thu, December 22, 2011
Valeant Pharmaceuticals Completes Acquisition of iNova
Valeant Pharmaceuticals Completes Acquisition of iNova -- MISSISSAUGA, Ontario, Dec. 22, 2011 /PRNewswire/ --
Valeant Pharmaceuticals Completes Acquisition of iNova
MISSISSAUGA, Ontario, Dec. 22, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: [ VRX ] and TSX: VRX) announced that effective December 21, 2011, the company completed its previously announced acquisition of iNova, from Archer Capital, Ironbridge and other minority management shareholders.
BofA Merrill Lynch and Baker & McKenzie acted as Valeant's advisors in connection with this transaction.
About Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant Pharmaceuticals International, Inc. can be found at [ www.valeant.com ].
(Logo: [ http://photos.prnewswire.com/prnh/20101025/LA87217LOGO ])
Contact Information:
Laurie W. Little
949-461-6002
[ laurie.little@valeant.com ]
SOURCE Valeant Pharmaceuticals International, Inc.
[ Back to top ] RELATED LINKS
[ http://www.valeant.com ]
